Smart biomaterials can reduce the risk of medical implant failure and accelerate patient recovery, according to a study conducted by the Ribeirão Preto Medical School of the University of São Paulo (USP) in Brazil. The study followed 99 patients who underwent hip and knee replacement surgery in 2020, revealing that 32.3% experienced complications within 30 days of discharge, with 12.1% suffering from local infections. This is a significant concern in various medical fields, including dentistry, where a 2022 study by the Federal University of Santa Catarina (UFSC) found a 7.1% failure rate in dental implants. These complications result in pain, additional costs, and prolonged recovery times for patients. To address this issue, the startup Extremus Smart Surfaces has developed a revolutionary solution: surfaces that interact with human cells and guide them toward faster and more efficient regeneration. This technology transforms common medical implants into smart biomaterials, reducing recovery time and failure rates. By optimizing the biological integration between the material and the organism through surface treatment, Extremus's technology significantly accelerates healing, even though it remains invisible to patients and doctors. The key to this innovation lies in the specific nanotopography, a microscopic structural configuration that closely interacts with cells. This nanotopography is confirmed by international scientific literature to positively influence implant integration, allowing the implant to attach better to the bone and reducing the chances of failure. Preclinical animal testing and studies with human bone marrow stem cells have shown significant improvements in fixation and bone production, respectively. Extremus's technology operates in three main segments: dental, orthopedic, and cardiovascular. The cardiovascular segment, in particular, is considered the most critical for implants, as devices must properly interact with the circulatory system, and any failure could have serious consequences. With an aging population and increasing demand for implants, Extremus's approach could revolutionize the future of regenerative medicine, accelerating healing and getting patients back on their feet more quickly. The company plans to expand internationally and has chosen an English name to facilitate this process. The technology is patented, and the startup licenses its technology to established manufacturers, transforming the surface of their products. The startup is currently focused on developing products for the cardiovascular segment, which has high impact potential. This innovation represents a paradigm shift in the design of medical implants, moving beyond mechanical fixations to a more holistic understanding of the healing process.
